Analysis of long-term outcome of image-guided volumetric modulated arc therapy (VMAT) for primary malignant tumor of the cervical spine

References

• Rosenberg AE. WHO classification of soft tissue and bone, fourth edition: summary and commentary. Curr Opin Oncol. 2013;25(5):571–573. doi:10.1097/01.cco.0000432522.16734.2d.
   PubMed Web of Science ®Google Scholar
• Walcott BP, Nahed BV, Mohyeldin A, Coumans J-V, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol. 2012;13(2):e69–e76. doi:10.1016/S1470-2045(11)70337-0.
   PubMed Web of Science ®Google Scholar
• Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergensg H. Ewing’s sarcoma family of tumors: current management. Oncologist. 2006;11(5):503–519. doi:10.1634/theoncologist.11-5-503.
   PubMed Web of Science ®Google Scholar
• Subbiah V, Anderson P, Lazar AJ, Burdett E, Raymond K, Ludwig JA. Ewing’s sarcoma: standard and experimental treatment options. Curr Treat Options Oncol. 2009;10(1–2):126–140. doi:10.1007/s11864-009-0104-6.
   PubMed Web of Science ®Google Scholar
• Federman N, Bernthal N, Eilber FC, Tap WD. The multidisciplinary management of osteosarcoma. Curr Treat Options Oncol. 2009;10(1–2):82–93. doi:10.1007/s11864-009-0087-3.
   PubMed Web of Science ®Google Scholar
• Cotterill SJ, Ahrens S, Paulussen M, Jürgens HF, Voûte PA, Gadner H, Craft AW. Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol. 2000;18(17):3108–3114. doi:10.1200/JCO.2000.18.17.3108.
   PubMed Web of Science ®Google Scholar
• Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2003;21(10):2011–2018. doi:10.1200/JCO.2003.08.132.
   PubMed Web of Science ®Google Scholar
• Wilartratsami S, Muangsomboon S, Benjarassameroj S, Phimolsarnti R, Chavasiri C, Luksanapruksa P. Prevalence of primary spinal tumors: 15-year data from Siriraj Hospital. J Med Assoc Thai. 2014;97(Suppl 9):S83–S87.
   PubMedGoogle Scholar
• Haji FA, Cenic A, Crevier L, Murty N, Reddy K. Minimally invasive approach for the resection of spinal neoplasm. Spine (Phila Pa 1976). 2011;36(15):E1018–E1026. doi:10.1097/BRS.0b013e31820019f9.
   PubMed Web of Science ®Google Scholar
• Tomita K, Kawahara N, Baba H, Tsuchiya H, Fujita T, Toribatake Y. Total en bloc spondylectomy. A new surgical technique for primary malignant vertebral tumors. Spine (Phila Pa 1976). 1997;22(3):324–333. doi:10.1097/00007632-199702010-00018.
   PubMed Web of Science ®Google Scholar
• Mcgovern SL, Mahajan A. Progress in radiotherapy for pediatric sarcomas. Curr Oncol Rep. 2012;14(4):320–326. doi:10.1007/s11912-012-0235-y.
   PubMed Web of Science ®Google Scholar
• Boriani S, Bandiera S, Biagini R, Bacchini P, Boriani L, Cappuccio M, Chevalley F, Gasbarrini A, Picci P, Weinstein JN, et al. Chordoma of the mobile spine: fifty years of experience. Spine (Phila Pa 1976). 2006;31(4):493–503. doi:10.1097/01.brs.0000200038.30869.27.
   PubMed Web of Science ®Google Scholar
• Stacchiotti S, Casali PG, Lo VS, Mariani L, Palassini E, Mercuri M, Alberghini M, Pilotti S, Zanella L, Gronchi A, et al. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol. 2010;17(1):211–219. doi:10.1245/s10434-009-0740-x.
   PubMed Web of Science ®Google Scholar
• Meng T, Yin H, Li B, Li Z, Xu W, Zhou W, Cheng M, Wang J, Zhou L, Yang X, et al. Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center. Neuro Oncol. 2015;17(5):725–732. doi:10.1093/neuonc/nou331.
   PubMed Web of Science ®Google Scholar
• Delaney TF, Liebsch NJ, Pedlow FX, Adams J, Weyman EA, Yeap BY, Depauw N, Nielsen GP, Harmon DC, Yoon SS, et al. Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas. J Surg Oncol. 2014;110(2):115–122. doi:10.1002/jso.v110.2.
   PubMed Web of Science ®Google Scholar
• Moojen WA, Vleggeert-Lankamp CL, Krol AD, Dijkstra SPD. Long-term results: adjuvant radiotherapy in en bloc resection of sacrococcygeal chordoma is advisable. Spine (Phila Pa 1976). 2011;36(10):E656–E661. doi:10.1097/BRS.0b013e3181f8d1f3.
   PubMed Web of Science ®Google Scholar
• Rotondo RL, Folkert W, Liebsch NJ, Chen YLE, Pedlow FX, Schwab JH, Rosenberg AE, Nielsen GP, Szymonifka J, Ferreira AE, et al. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. J Neurosurg Spine. 2015;23(6):788–797. doi:10.3171/2015.3.SPINE14716.
   PubMed Web of Science ®Google Scholar
• Dominkus M, Ruggieri P, Bertoni F, Briccoli A, Picci P, Rocca M, Mercuri M. Histologically verified lung metastases in benign giant cell tumours–14 cases from a single institution. Int Orthop. 2006;30(6):499–504. doi:10.1007/s00264-006-0204-x.
   PubMed Web of Science ®Google Scholar
• Viswanathan S, Jambhekar NA. Metastatic giant cell tumor of bone: are there associated factors and best treatment modalities? Clin Orthop Relat Res. 2010;468(3):827–833. doi:10.1007/s11999-009-0966-8.
   PubMed Web of Science ®Google Scholar
• Saiz P, Virkus W, Piasecki P, Templeton A, Shott S, Gitelis S. Results of giant cell tumor of bone treated with intralesional excision. Clin Orthop Relat Res. 2004;(424):221–226. doi:10.1097/01.blo.0000128280.59965.e3.
   PubMed Web of Science ®Google Scholar
• Malek F, Krueger P, Hatmi ZN,Malayeri, AA, Faezipour, H, O’Donnell, RJ. Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy. Int Orthop. 2006;30(6):495–498. doi:10.1007/s00264-006-0146-3.
   PubMed Web of Science ®Google Scholar
• Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HCF, Jorgensen PH, Bergh P, Follerås G. Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop. 2008;79(1):86–93. doi:10.1080/17453670710014815.
   PubMed Web of Science ®Google Scholar
• Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, Rossi G, Longhi A, Mercuri M. Giant cell tumor of the extremity: A review of 349 cases from a single institution. Cancer Treat Rev. 2010;36(1):1–7. doi:10.1016/j.ctrv.2009.09.002.
   PubMed Web of Science ®Google Scholar
• Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res. 2011;469(2):591–599. doi:10.1007/s11999-010-1501-7.
   PubMed Web of Science ®Google Scholar
• Su YP, W M C, Chen TH. Giant-cell tumors of bone: an analysis of 87 cases. Int Orthop. 2004;28(4):239–243. doi:10.1007/s00264-004-0564-z.
   PubMed Web of Science ®Google Scholar
• Guo W, Sun X, Zang J, Qu H. Intralesional excision versus wide resection for giant cell tumor involving the acetabulum: which is better? Clin Orthop Relat Res. 2012;470(4):1213–1220. doi:10.1007/s11999-011-2190-6.
   PubMed Web of Science ®Google Scholar
• Ruka W, Rutkowski P, Morysinski T, Nowecki Z, Zdzienicki M, Makula D, Ptaszyński K, Bylina E, Grzesiakowska U. The megavoltage radiation therapy in treatment of patients with advanced or difficult giant cell tumors of bone. Int J Radiat Oncol Biol Phys. 2010;78(2):494–498. doi:10.1016/j.ijrobp.2009.07.1704.
   PubMed Web of Science ®Google Scholar
• Bhatia S, Miszczyk L, Roelandts M, Nguyen TD, Boterberg T, Poortmans P, Vallow L, Dincbas FO, Lassen-Ramshad Y, Botros M, et al. Radiotherapy for marginally resected, unresectable or recurrent giant cell tumor of the bone: a rare cancer network study. Rare Tumors. 2011;3(4):e48. doi:10.4081/rt.2011.e48.
   PubMedGoogle Scholar
• Ma Y, Xu W, Yin H, et al. Therapeutic radiotherapy for giant cell tumor of the spine: a systemic review. Eur Spine J. 2015;24(8):1754–1760. doi:10.1007/s00586-015-3834-0.
   PubMed Web of Science ®Google Scholar
• Miszczyk L, Wydmanski J, Spindel J. Efficacy of radiotherapy for giant cell tumor of bone: given either postoperatively or as sole treatment. Int J Radiat Oncol Biol Phys. 2001;49(5):1239–1242. doi:10.1016/S0360-3016(00)01520-0.
   PubMed Web of Science ®Google Scholar
• Caudell JJ, Ballo MT, Zagars GK, Lewis VO, Weber KL, Lin PP, Marco RA, El-Naggar AK, Benjamin RS, Yasko AW, et al. Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys. 2003;57(1):158–165. doi:10.1016/S0360-3016(03)00416-4.
   PubMed Web of Science ®Google Scholar
• Mang Q, Dang G, Liu Z, Qiang CZ, Guang LX. Diagnosis and treatment of 36 cases of giant cell tumor of the spine. J Peking Univ (Health Sci). 2002;(6):656–659.
   Google Scholar
• Goda JS, Ferguson PC, O’Sullivan B, Catton CN, Griffin AM, Wunder JS, Bell RS, Kandel RA, Chung PW. 2011. High-risk extracranial chondrosarcoma: long-term results of surgery and radiation therapy. Cancer. 117(11):2513–2519.
   PubMed Web of Science ®Google Scholar
• Kawaguchi S, Weiss I, Lin PP, Huh WW, Lewis VO. Radiation therapy is associated with fewer recurrences in mesenchymal chondrosarcoma. Clin Orthop Relat Res. 2014;472(3):856–864. doi:10.1007/s11999-013-3064-x.
   PubMed Web of Science ®Google Scholar